Director of Global Product Management, Women’s Health at QIAGEN
Ha Thai has worked exclusively on development and promotion of QIAGEN’s Women’s Health portfolio for over 16 years. Ha has a background in molecular biology receiving a Master Degree in Pathology from Georgetown University, focusing on cancer research including working in the labs of some of the Researchers critical to the development of the HPV vaccine. Ha’s QIAGEN career began with digene the developers of the first FDA approved HPV DNA Test to be used for diagnostics where he worked for 12+ years in R&D focusing on new assay development. His current focus at QIAGEN is managing the extensive Women’s Health portfolio, including the care HPV product line developed specifically for HPV detection in low resource settings. QIAGEN has been committed to the eradication of cervical cancer as demonstrated in our partnerships and philanthropic endeavors with numerous non-profit and NGOs all with the same goal of bringing affordable cervical cancer prevention solutions to every women.